PAX6, a novel target of miR-335, inhibits cell proliferation and invasion in glioma cells
Authors:
Open Access
- 15 April 2014
- journal article
- retracted article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 10 (1) , 399-404
Abstract
Paired box 6 (PAX6), a highly conserved transcription factor, is important in glioma. However, the molecular mechanisms involved remain unclear. The present study demonstrated that the expression of PAX6 was significantly reduced with the malignancy of glioma and also identified PAX6 as a novel target of microRNA (miR)‑335, which was significantly upregulated in glioma. The inhibition of miR‑335 increased the protein expression of PAX6, whereas the upregulation of miR‑335 suppressed its expression in human glioma U251 and U87 cells. Furthermore, upregulation of miR-335 promoted U251 cell proliferation, colony formation and invasion, which was reversed by the overexpression of PAX6. Furthermore, the present study demonstrated that the effect of miR‑335 on U251 cell invasion was via the modulation of matrix metalloproteinase (MMP)‑2 and MMP‑9 expression by targeting PAX6. In conclusion, the present study demonstrated that PAX6, as a novel target of miR‑335, has an anti‑oncogenic function in glioma, and thus PAX6 may serve as a therapeutic target for glioma.Keywords
This publication has 29 references indexed in Scilit:
- Pax6 Interactions with Chromatin and Identification of Its Novel Direct Target Genes in Lens and ForebrainPLOS ONE, 2013
- Pax6: A multi-level regulator of ocular developmentProgress in Retinal and Eye Research, 2012
- Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapyExpert Opinion on Investigational Drugs, 2012
- Understanding the role of cytokines in Glioblastoma Multiforme pathogenesisCancer Letters, 2012
- Glucagon gene expression in the endocrine pancreas: the role of the transcription factor Pax6 in α ‐cell differentiation, glucagon biosynthesis and secretionDiabetes, Obesity and Metabolism, 2011
- Molecularly targeted therapy for malignant gliomaCancer, 2007
- PAX6 Suppresses the Invasiveness of Glioblastoma Cells and the Expression of the Matrix Metalloproteinase-2 GeneCancer Research, 2006
- Gene Therapy for Malignant Glioma: Current Clinical StatusMolecular Therapy, 2005
- The functions of animal microRNAsNature, 2004
- Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trialsThe Lancet, 2002